Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ:TARS) through any online brokerage.
Other companies in Tarsus Pharmaceuticals’s space includes: Bioage Labs (NASDAQ:BIOA), WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN), Rapport Therapeutics (NASDAQ:RAPP) and Phibro Animal Health (NASDAQ:PAHC).
Tarsus Pharmaceuticals has a consensus price target of $50.14.
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $34.3 last updated October 7, 2024 at 7:57 PM EDT.
There are no upcoming dividends for Tarsus Pharmaceuticals.
Tarsus Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Tarsus Pharmaceuticals.
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.